In the last 12 months, insiders at ONCOLYTICS BIOTECH INC ($ONCY) filed 14 transactions with the SEC: 14 open-market purchases totaling $362,615 and 0 sales totaling $0. Net insider sentiment: net buying.
ONCOLYTICS BIOTECH INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Seizinger Bernd R. (Director) — 3 transactions totaling $187,224
- Kelly Jared (Chief Executive Officer) — 3 transactions totaling $34,369
- Andrews Patricia S (Director) — 1 transaction totaling $30,292
- Aromando Andrew (Chief Business Officer) — 1 transaction totaling $25,418
- Pisano Wayne (Director) — 1 transaction totaling $25,338
View all SEC Filings for ONCOLYTICS BIOTECH INC (ONCY).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Kelly Jared | Chief Executive Officer | P | Common Shares | 5050 | $0.96 | 114,050.0000 | 80,020,131 | 4.63% | 0.01% |
| March 11, 2026 | Parsons James T. | Director | P | Common Shares | 10000 | $1.03 | 41,849.0000 | 80,020,131 | 31.40% | 0.01% |
| Feb. 12, 2026 | Look Kirk | Chief Financial Officer | P | Common Shares | 12000 | $0.84 | 287,515.0000 | 80,020,131 | 4.36% | 0.01% |
| Feb. 12, 2026 | Pisano Wayne | Director | P | Common Shares | 30000 | $0.84 | 492,414.0000 | 80,020,131 | 6.49% | 0.04% |
| Feb. 12, 2026 | Heineman Thomas Charles | Chief Medical Officer | P | Common Shares | 12132 | $0.83 | 282,818.0000 | 80,020,131 | 4.48% | 0.02% |
| Feb. 12, 2026 | Brown Deborah Margaret | Director | P | Common Shares | 25000 | $0.85 | 109,851.0000 | 80,020,131 | 29.46% | 0.03% |
| Feb. 12, 2026 | Hagerman Allison | VP, Product Development | P | Common Shares | 10000 | $0.83 | 115,059.0000 | 80,020,131 | 9.52% | 0.01% |
| Feb. 11, 2026 | Kelly Jared | Chief Executive Officer | P | Common Shares | 5600 | $0.84 | 79,500.0000 | 80,020,131 | 7.58% | 0.01% |
| Feb. 12, 2026 | Seizinger Bernd R. | Director | P | Common Shares | 40000 | $0.85 | 566,991.0000 | 80,020,131 | 7.59% | 0.05% |
| Feb. 11, 2026 | Aromando Andrew | Chief Business Officer | P | Common Shares | 29600 | $0.86 | 55,100.0000 | 80,020,131 | 116.08% | 0.04% |
| Feb. 12, 2026 | Andrews Patricia S | Director | P | Common Shares | 35400 | $0.86 | 78,128.0000 | 80,020,131 | 82.85% | 0.04% |
| Feb. 11, 2026 | Seizinger Bernd R. | Director | P | Common Shares | 60000 | $0.83 | 526,991.0000 | 80,020,131 | 12.85% | 0.07% |
| Feb. 12, 2026 | Kelly Jared | Chief Executive Officer | P | Common Shares | 29500 | $0.84 | 109,000.0000 | 80,020,131 | 37.11% | 0.04% |
| Jan. 16, 2026 | Seizinger Bernd R. | Director | P | Common Shares | 100000 | $1.04 | 466,991.0000 | 80,020,131 | 27.25% | 0.12% |